Retatrutide 5mg – Triple Agonist Research Peptide

Retatrutide is a next-generation investigational peptide known for its potential impact on body weight management and metabolic regulation. It combines activity across GLP-1, GIP, and glucagon receptors—targeting multiple pathways involved in appetite control, glucose metabolism, and fat oxidation.

This 5mg strength vial is ideal for those conducting research into weight loss, body recomposition, or hormone-based metabolic interventions.

Suggested Use

For an 8-week research protocol, typical starting dosages may range from 0.25mg to 1.0mg per week, gradually increasing based on tolerance and research goals. Always consult professional guidelines and safety protocols when conducting peptide-based studies.

Suggested 8-Week Research Protocol:

• Week 1–2: 0.25mg per week
• Week 3–4: 0.5mg per week
• Week 5–6: 0.75mg per week
• Week 7–8: 1.0mg per week

Whats in the box

• 1 x vial 5mg Retatrutide
• 1x 1.2ml Vial Bacteriostatic water for recombination